(Q34737840)

4 August 2017

1 reference

title

Antibody responses in parvovirus B19 infected patients (English)

1 reference

4 August 2017

1 reference

Susanne Modrow

1

1 reference

PubMed ID

12116851

4 August 2017

Simone Dorsch

series ordinal

2

1 reference

4 August 2017

1 June 2002

1 reference

4 August 2017

Pathology and Biology

1 reference

4 August 2017

50

1 reference

4 August 2017

5

1 reference

4 August 2017

326-331

1 reference

Parvovirus-like particles in human sera

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Human parvovirus, the cause of erythema infectiosum (fifth disease)?

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Polyarteritis nodosa and parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Chronic autoimmune thrombopenia/neutropenia in a boy with persistent parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Human parvovirus B19 and arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Another viral candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Immediate and long term outcome of human parvovirus B19 infection in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Human parvovirus infection in homozygous sickle cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Chronic bone marrow failure due to persistent B19 parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Candidate recombinant vaccine for human B19 parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Most of the VP1 unique region of B19 parvovirus is on the capsid surface

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Sequence variability among different parvovirus B19 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Erythrocyte P antigen: cellular receptor for B19 parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Mapping of B-cell epitopes on human parvovirus B19 non-structural and structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Cellular transcription factors that interact with p6 promoter elements of parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

NS1 protein of parvovirus B19 interacts directly with DNA sequences of the p6 promoter and with the cellular transcription factors Sp1/Sp3.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Antibodies to parvovirus B19 NS-1 protein in infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Immunoreactivity against linear epitopes of parvovirus B19 structural proteins. Immunodominance of the amino-terminal half of the unique region of VP1

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Persistent parvovirus B19 infections in immunocompromised children

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin--a report of eight patients

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Parvovirus B19 as a cause of chronic anemia in rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Chronic parvovirus infection in a presumably immunologically healthy woman

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Persistent infection of human parvovirus B19 in a normal subject

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

There is no association between polymyalgia rheumatica and acute parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2802%2900302-4

7 January 2021

10.1016/S0369-8114(02)00302-4

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12116851